Diagnosing cancer may soon become easier and less painful thanks to advances in AI-assisted blood and urine tests.
Scientists believe these tests could one day detect cancer by analyzing tiny particles called exosomes, which carry messages from cells and reflect what is happening inside tumors.
Exosomes are small particles released by most cells. In people with cancer, they contain special molecular signals—proteins, genes, and other materials—that provide a detailed look at tumor behavior.
By studying these exosomes, scientists can find early signs of cancer and track how it responds to treatment.
Researchers from the University of Sharjah reviewed over 100 studies and found that using artificial intelligence (AI) to analyze exosome data—along with multi-omics (proteomics, genomics, metabolomics, and lipidomics)—makes it possible to detect cancer earlier and more accurately. AI helps identify patterns too complex for humans to see.
Instead of needing painful tissue biopsies, doctors may soon use a liquid biopsy—just a drop of blood or a small sample of urine. These simple tests could find cancer, track its development, and guide treatment choices with precision.
Exosomes might not only detect cancer—they could also help treat it. Scientists are exploring how to load them with medicine to target tumors directly, reducing side effects and improving results. Experts believe these advances will make personalized cancer care a reality in everyday health care.
This new research shows that AI-powered tests using exosomes have great promise. They could lead to earlier diagnosis, better monitoring, and more effective treatment—transforming how cancer is managed in the future.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and vitamin D supplements could strongly reduce cancer death.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing higher intake of dairy foods linked to higher prostate cancer risk.
The study is published in Clinica Chimica Acta.
Copyright © 2025 Knowridge Science Report. All rights reserved.
